UNSPSC 51391713: Clorprenaline

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3W4327W76O. European Medicines Agency schedules Clorprenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06766MIG. Clorprenaline generally arises in the molecular formula C11H16CLNO. The term CLORPRENALINE is an International Non-Proprietary Name or INN. CLORPRENALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule clorprenaline under HS 29221980 and SITC 51461. As of Q4 2014, CLORPRENALINE remains the US FDA Preferred Term for this commodity. Clorprenaline bears US NLM identifiers UMLS ID C0055943 and NCI Concept Code C83633. SMILES: CC(C)NCC(C1=CC=CC=C1CL)O.

UNSPSC 51391713 Clorprenaline is a Commodity code that captures pharmaceutical procurement by state and local health agencies, though recent solicitation activity under this code shows limited alignment with the nominal product category. The single recent opportunity posted involves Seminole County, Florida's procurement of naloxone and drug deactivation systems through competitive sealed bidding, a health and emergency-response focused purchase rather than clorprenaline specifically. State and local governments use codes in this family to acquire pharmaceutical products and medical supplies for community health programs, emergency response, and public health initiatives, with issuing bodies including county health departments and community health authorities.

Seminole County, Florida posted the only recent activity identified under this code—IFB 60459723LAS, released June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford. The procurement is a fixed-fee competitive bid with a two-year initial term and one-year renewal option, requiring E-Verify compliance, drug-free workplace certification, and specific insurance coverages. FEMA potential funding introduces federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The mismatch between the code's nominal scope and the actual goods solicited suggests limited ongoing state and local procurement activity specifically for clorprenaline, with this code showing more pharmaceutical acquisition activity in emergency-response and public health contexts than in its primary product category.